Governor Wes Moore announced December 23, 2025, that Maryland has exceeded all targets set under the Governor’s ...

Maryland data centers could create thousands of jobs, boost tax revenue and help close the state’s $1.5B deficit, but energy ...

The data presented covered everything from its mainstay acalabrutinib, sold as Calquence, to the eye-catching AZD0120, an ...

Maryland’s Prescription Drug Affordability Board (PDAB) serves as a bellwether for how other states may address high drug ...

Dupilumab, a fully human monoclonal antibody, inhibits the signaling of the interleukin 4 (IL-4) and IL-13 pathways.

Tuesday, December 30, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Berkshire ...

IonQ's next-generation Tempo 100 quantum system will help create the first instance of hybrid quantum-classical onsite ...

The CLL17 trial showed noninferiority of fixed-duration regimens compared to continuous BTK inhibitor therapy, highlighting ...

Semaglutide use is linked to fewer hospitalizations and fewer days in the hospital for patients with cardiovascular disease ...

Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive ...

The year saw the emergence of a new version of an old drug that proved beneficial in patients who have heart failure with ...

Less than two years after buying Chinese biotech Gracell for its cell therapy platform, AstraZeneca has reported encouraging clinical results with the lead CAR-T from the deal, GC012F (now AZD0120), ...